114 related articles for article (PubMed ID: 10954906)
1. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.
Bachoud-Lévi AC; Déglon N; Nguyen JP; Bloch J; Bourdet C; Winkel L; Rémy P; Goddard M; Lefaucheur JP; Brugières P; Baudic S; Cesaro P; Peschanski M; Aebischer P
Hum Gene Ther; 2000 Aug; 11(12):1723-9. PubMed ID: 10954906
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
Bloch J; Bachoud-Lévi AC; Déglon N; Lefaucheur JP; Winkel L; Palfi S; Nguyen JP; Bourdet C; Gaura V; Remy P; Brugières P; Boisse MF; Baudic S; Cesaro P; Hantraye P; Aebischer P; Peschanski M
Hum Gene Ther; 2004 Oct; 15(10):968-75. PubMed ID: 15585112
[TBL] [Abstract][Full Text] [Related]
3. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.
Mittoux V; Joseph JM; Conde F; Palfi S; Dautry C; Poyot T; Bloch J; Deglon N; Ouary S; Nimchinsky EA; Brouillet E; Hof PR; Peschanski M; Aebischer P; Hantraye P
Hum Gene Ther; 2000 May; 11(8):1177-87. PubMed ID: 10834619
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.
Aebischer P; Pochon NA; Heyd B; Deglon N; Joseph JM; Zurn AD; Baetge EE; Hammang JP; Goddard M; Lysaght M; Kaplan F; Kato AC; Schluep M; Hirt L; Regli F; Porchet F; De Tribolet N
Hum Gene Ther; 1996 May; 7(7):851-60. PubMed ID: 8860837
[TBL] [Abstract][Full Text] [Related]
6. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease.
Emerich DF; Lindner MD; Winn SR; Chen EY; Frydel BR; Kordower JH
J Neurosci; 1996 Aug; 16(16):5168-81. PubMed ID: 8756445
[TBL] [Abstract][Full Text] [Related]
7. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
Emerich DF; Bruhn S; Chu Y; Kordower JH
Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
[TBL] [Abstract][Full Text] [Related]
8. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
[TBL] [Abstract][Full Text] [Related]
9. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent neurochemical and functional protection afforded by encapsulated CNTF-producing cells.
Emerich DF
Cell Transplant; 2004; 13(7-8):839-44. PubMed ID: 15690987
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum.
Emerich DF; Winn SR
Cell Transplant; 2004; 13(3):253-9. PubMed ID: 15191163
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
Régulier E; Pereira de Almeida L; Sommer B; Aebischer P; Déglon N
Hum Gene Ther; 2002 Nov; 13(16):1981-90. PubMed ID: 12427308
[TBL] [Abstract][Full Text] [Related]
13. Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
Denovan-Wright EM; Attis M; Rodriguez-Lebron E; Mandel RJ
J Neurosci Res; 2008 Jun; 86(8):1748-57. PubMed ID: 18293418
[TBL] [Abstract][Full Text] [Related]
14. Technology evaluation: CRIB (CNTF delivery) CytoTherapeutics Inc.
Abicht A; Lochmüller H
Curr Opin Mol Ther; 1999 Oct; 1(5):645-50. PubMed ID: 11249671
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
de Almeida LP; Zala D; Aebischer P; Déglon N
Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated CNTF-producing cells for Huntington's disease.
Emerich DF
Cell Transplant; 1999; 8(6):581-2. PubMed ID: 10701486
[No Abstract] [Full Text] [Related]
17. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.
Déglon N; Heyd B; Tan SA; Joseph JM; Zurn AD; Aebischer P
Hum Gene Ther; 1996 Nov; 7(17):2135-46. PubMed ID: 8934227
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.
Aebischer P; Schluep M; Déglon N; Joseph JM; Hirt L; Heyd B; Goddard M; Hammang JP; Zurn AD; Kato AC; Regli F; Baetge EE
Nat Med; 1996 Jun; 2(6):696-9. PubMed ID: 8640564
[TBL] [Abstract][Full Text] [Related]
19. Intracompartmental delivery of CNTF as therapy for Huntington's disease and retinitis pigmentosa.
Emerich DF; Thanos CG
Curr Gene Ther; 2006 Feb; 6(1):147-59. PubMed ID: 16475952
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for Huntington's disease.
Ramaswamy S; Kordower JH
Neurobiol Dis; 2012 Nov; 48(2):243-54. PubMed ID: 22222669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
